Clinical Trial

Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients

Study acronym: TIR-REAL
Completed
View on ClinicalTrials.gov →
Summary
This multicenter retrospective observational study evaluates the real-world use of tirzepatide in adult patients with post-bariatric weight regain and in patients with obesity undergoing preoperative management. The study analyzes changes in body weight and metabolic parameters, as well as treatment tolerability and safety, during routine clinical care. No experimental interventions are performed, and all patients receive tirzepatide as part of standard medical practice.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-26.
Trial Details
NCT Number NCT07382180
Lead Sponsor Azienda Sanitaria Locale Napoli 2 Nord
Conditions Obesity & Overweight, Weight Regain, Obesity, Morbid
Enrollment 254 participants
Start Date 2025-02-01
Primary Completion 2026-01-18 (estimated)
Study Completion 2026-01-18 (estimated)
Updated on ClinicalTrials.gov 2026-02-03